Dr. Nicola Maurea is graduated in Medicine and he is specialized in Cardiology and Internal Medicine; he has obtained all degrees with full marks and honors from University of Naples Federico II.

He is the Director of Division of Cardiology of National Cancer Institute, Pascale Foundation, Naples. He is a distinguished expert in the field of  Cardioncology and he is President of Italian Association of Cardioncology.

Moreover he is Fellow of the American College of Cardiology and Fellow of the European Society of Cardiology.

He is author of many papers in international peer reviewed journals and many abstracts presented at international meetings of cardiological and oncological societies and he has been invited speaker many times at international and national conferences.

• Cardioncology
• Cardiotoxicity
• Cardiology
• Prevention
• Cancer

• Vincenzo Quagliariello , Massimiliano Berretta, Irma Bisceglia,Martina Iovine, Matteo Barbato, Raffaele Arianna, Maria Laura Canale, AndreaPaccone, Alessandro Inno, Marino Scherillo, Stefano Oliva, Christian CadedduDessalvi, Alfredo Mauriello, Carlo Maurea, Celeste Fonderico, Anna ChiaraMarateaDomenico Gabrielli, Nicola Maurea PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced bySequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 PathwayInhibition - Int. J. Mol. Sci. 2025, 26(14), 6617; https://doi.org/10.3390/ijms26146617
• Ciappina G, Ottaiano A, Santorsola M, Esposito E, De Luca F, Giorgi C, Zito C, Capra AP, Carroccio P, Maurea N, Quagliariello V, Campo I, Passalacqua MI, Incognito D, Cacciola I, Consolo P, Berretta M. Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies. Cancers (Basel). 2025 Jul 3;17(13):2228. doi: 10.3390/cancers17132228. PMID: 40647526.
• Mauriello A, Correra A, Del Vecchio GE, Grieco M, Amata A, Di Micco P, Imbalzano E, Paternoster M, Ascrizzi A, Quagliariello V, Maurea N, Giallauria F, D'Andrea A, Russo V. Heart Failure and Wide QRS: Clinical and Pharmacological Perspectives. Biomedicines. 2025 Jun 13;13(6):1462. doi: 10.3390/biomedicines13061462. PMID: 40564182; PMCID: PMC12190266.
• Greco A, Canale ML, Quagliariello V, Oliva S, Tedeschi A, Inno A, De Biasio M, Bisceglia I, Tarantini L, Maurea N, Navazio A, Corda M, Iacovoni A, Colivicchi F, Grimaldi M, Oliva F. SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology. Int J Mol Sci. 2025 May 16;26(10):4780. doi: 10.3390/ijms26104780. PMID: 40429921; PMCID: PMC12112039.
• Quagliariello V, Di Mauro A, Ferrara G, Bruzzese F, Palma G, Luciano A, Canale ML, Bisceglia I, Iovine M, Cadeddu Dessalvi C, Maurea C, Barbato M, Inno A, Berretta M, Paccone A, Mauriello A, Fonderico C, Maratea AC, Maurea N. Cardio-Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity. Antioxidants (Basel). 2025 May 20;14(5):612. doi: 10.3390/antiox14050612. PMID: 40427493; PMCID: PMC12108597.
• Mauriello A, Giudice CD, Vecchio GED, Correra A, Maratea AC, Grieco M, Amata A, Quagliariello V, Maurea N, Proietti R, Giordano A, D'Andrea A, Russo V. Takotsubo Syndrome and Oxidative Stress: Physiopathological Linkage and Future Perspectives. Antioxidants (Basel). 2025 Apr 27;14(5):522. doi: 10.3390/antiox14050522. PMID: 40427405; PMCID: PMC12108290.
• Berretta M, Quagliariello V, Ottaiano A, Santorsola M, Di Francia R, Carroccio P, Maurea N, Buonomo OC, Facchini G, Di Mauro G, Montopoli M, Toscano E, Gelsomino C, Picone A, Franchina T, Muscolino P, Bignucolo A, Vanni G, Ciappina G, Montella L. Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective Study. Nutrients. 2025 Mar 13;17(6):1012. doi: 10.3390/nu17061012. PMID: 40290037; PMCID: PMC11945461.
• Quagliariello V, Berretta M, Bisceglia I, Giacobbe I, Iovine M, Barbato M, Maurea C, Canale ML, Paccone A, Inno A, Scherillo M, Oliva S, Cadeddu Dessalvi C, Mauriello A, Fonderico C, Maratea AC, Gabrielli D, Maurea N. In the Era of Cardiovascular-Kidney-Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy. Cancers (Basel). 2025 Mar 30;17(7):1169. doi: 10.3390/cancers17071169. PMID: 40227756; PMCID: PMC11988012.
• Fazzini L, Campana N, Cossu S, Deidda M, Madaudo C, Quagliariello V, Maurea N, Di Lisi D, Novo G, Zito C, Cadeddu Dessalvi C. Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy. J Clin Med. 2025 Feb 15;14(4):1286. doi: 10.3390/jcm14041286. PMID: 40004816; PMCID: PMC11856774.
• Ottaiano A, Facchini BA, Iacovino M, Santorsola M, Facchini S, Di Mauro G, Toscano E, Montopoli M, Di Mauro A, Quagliariello V, Maurea N, Vanni G, Bignucolo A, Montella L, Materazzo M, Roselli M, Buonomo OC, Berretta M. Impact of Vitamin D Levels on Progression-Free Survival and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Cancers (Basel). 2024 Dec 17;16(24):4206. doi: 10.3390/cancers16244206. PMID: 39766105; PMCID: PMC11674590.
• Quagliariello V, Canale ML, Bisceglia I, Iovine M, Giordano V, Giacobbe I, Scherillo M, Gabrielli D, Maurea C, Barbato M, Inno A, Berretta M, Tedeschi A, Oliva S, Greco A, Maurea N. Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients. Int J Mol Sci. 2024 Oct 21;25(20):11299. doi: 10.3390/ijms252011299. PMID: 39457081; PMCID: PMC11508560.
• Canale ML, Greco A, Inno A, Tedeschi A, De Biasio M, Oliva S, Bisceglia I, Maurea N, Tarantini L, Gallucci G, Gulizia MM, Turazza FM, Lucà F, Di Fusco SA, Riccio C, Navazio A, De Luca L, Gabrielli D, Colivicchi F, Grimaldi M, Oliva F. Aterosclerosi, cancro e inibitori dei checkpoint immunitari [Atherosclerosis, cancer and immune checkpoint inhibitors]. G Ital Cardiol (Rome). 2024 Oct;25(10):711-719. Italian. doi: 10.1714/4336.43213. PMID: 39342555.
• Wahab MA, Del Gaudio N, Gargiulo B, Quagliariello V, Maurea N, Nebbioso A, Altucci L, Conte M. Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer. Cancers (Basel). 2024 Aug 30;16(17):3026. doi: 10.3390/cancers16173026. PMID: 39272883; PMCID: PMC11394081.
• Serri C, Quagliariello V, Cruz-Maya I, Guarino V, Maurea N, Giunchedi P, Rassu G, Gavini E. Hyaluronic Acid-Based Nanoparticles Loaded with Rutin as Vasculo-Protective Tools against Anthracycline-Induced Endothelial Damages. Pharmaceutics. 2024 Jul 25;16(8):985. doi: 10.3390/pharmaceutics16080985. PMID: 39204330; PMCID: PMC11357640.
• Quagliariello V, Canale ML, Bisceglia I, Maurea C, Gabrielli D, Tarantini L, Paccone A, Inno A, Oliva S, Cadeddu Dessalvi C, Zito C, Caraglia M, Berretta M, D'Aiuto G, Maurea N. Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism. Biomedicines. 2024 Jul 24;12(8):1650. doi: 10.3390/biomedicines12081650. PMID: 39200115; PMCID: PMC11351439.
• Bisceglia I, Venturini E, Canale ML, Ambrosetti M, Riccio C, Giallauria F, Gallucci G, Abrignani MG, Russo G, Lestuzzi C, Mistrulli R, De Luca G, Maria Turazza F, Mureddu G, Di Fusco SA, Lucà F, De Luca L, Camerini A, Halasz G, Camilli M, Quagliariello V, Maurea N, Fattirolli F, Gulizia MM, Gabrielli D, Grimaldi M, Colivicchi F, Oliva F. Cardio-oncology rehabilitation: are we ready? Eur Heart J Suppl. 2024 May 16;26(Suppl 2):ii252-ii263. doi: 10.1093/eurheartjsupp/suae030. PMID: 38784673; PMCID: PMC11110456.
• Quagliariello V, Berretta M, Bisceglia I, Giacobbe I, Iovine M, Giordano V, Arianna R, Barbato M, Izzo F, Maurea C, Canale ML, Paccone A, Inno A, Scherillo M, Gabrielli D, Maurea N. The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients. Cancers (Basel). 2024 Apr 12;16(8):1487. doi: 10.3390/cancers16081487. PMID: 38672567; PMCID: PMC11047880.
• Bisceglia I, Venturini E, Canale ML, Ambrosetti M, Riccio C, Giallauria F, Gallucci G, Abrignani MG, Russo G, Lestuzzi C, Mistrulli R, De Luca G, Turazza F, Mureddu GF, Di Fusco SA, Lucà F, De Luca L, Camerini A, Halasz G, Camilli M, Quagliariello V, Maurea N, Fattirolli F, Gulizia MM, Gabrielli D, Grimaldi M, Colivicchi F, Oliva F. Position paper ANMCO in collaborazione con ITACARE-P: Riabilitazione cardio-oncologica. “Are we ready?” [ANMCO Position paper in collaboration with ITACARE-P: Cardio-oncology rehabilitation. Are we ready?]. G Ital Cardiol (Rome). 2024 Apr;25(4):281-293. Italian. doi: 10.1714/4244.42210. PMID: 38526365.
• Combinatorial immune checkpoint blockadeincreasesmyocardialexpression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemicalimplications in cardio-immuno-oncology. Quagliariello V, Passariello M, Bisceglia I, Paccone A, Inno A, Maurea C, Rapuano Lembo R, Manna L, Iovine M, Canale ML, Scherillo M, Ascierto PA, Gabrielli D, De Lorenzo C, Maurea N.Front CardiovascMed. 2024 Jan 23;11:1232269. doi: 10.3389/fcvm.2024.1232269. eCollection 2024.PMID: 38322766
• Circulatingvitamin D levelbeforeinitiatingchemotherapyimpacts on the time-to-outcome in metastaticcolorectalcancerpatients: systematicreview and meta-analysis.
• Ottaiano A, Iacovino ML, Santorsola M, Facchini S, Iervolino D, Perri F, Nasti G, Quagliariello V, Maurea N, Ronchi A, Facchini BA, Bignucolo A, Berretta M.J TranslMed. 2024 Jan 30;22(1):119. doi: 10.1186/s12967-024-04889-2.PMID: 38291479
• Correction: Cisplatinresistance can be curtailed by blunting Bnip3-mediated mitochondrialautophagy.Vianello C, Cocetta V, Catanzaro D, Dorn GW 2nd, De Milito A, Rizzolio F, Canzonieri V, Cecchin E, Roncato R, Toffoli G, Quagliariello V, Di Mauro A, Losito S, Maurea N, Scaffa C, Sales G, Scorrano L, Giacomello M, Montopoli M.Cell Death Dis. 2024 Jan 18;15(1):68. doi: 10.1038/s41419-023-06402-x.PMID: 38238295
• SGLT2i Dapagliflozindecreases NLRP3, IL-1 and PCSK9 expression in preclinicalmodels of short-termdoxorubicincardiotoxicity. A. Bonelli, M.L. Canale , I. Bisceglia , G. Palma , A. Luciano, F. Bruzzese , F. Russo , V. Giordano , C. Maurea , A. Paccone , M. Iovine , F. Florio , MaureaN., V. Quagliariello. Anti CTLA-4 and PD-1 monoclonalantibodiesincreasessystemic SDF-1 and galectin-3 levels and reducesmyocardialstrainthrough NLRP3 and MyD-88 pathways. Maurea N, C De Lorenzo, M Passariello, A Di Mauro, C Cipullo, I Bisceglia, A Paccone, M Iovine, F Florio, S Grimaldi, V Giordano, F Bruzzese, G Palma, A Luciano, V Quagliariello.November 2023Circulation 148(Suppl_1) DOI: 10.1161/circ.148.suppl_1.15045
• Corrigendum: Cancersurvivorshipatheart: a multidisciplinary cardio-oncologyroadmap for healthcareprofessionals.Irma Bisceglia, Maria Laura Canale, Nicola Silvestris, Giuseppina Gallucci, Andrea Camerini, Alessandro Inno, Massimiliano Camilli, Fabio Maria Turazza, Giulia Russo, Andrea Paccone, Raffaella Mistrulli, Leonardo De Luca, Stefania Angela Di Fusco, Luigi Tarantini, Fabiana Lucà, Stefano Oliva, Antonella Moreo, Maurea N., Vincenzo Quagliariello, Giuseppina Rosaria Ricciardi, Chiara Lestuzzi, Damiana Fiscella, Iris Parrini, Vito Racanelli, Antonio Russo, Lorena Incorvaia, Fabio Calabrò, Giuseppe Curigliano, Saverio Cinieri, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, and Furio Colivicchi DOI: 10.3389/fcvm.2023.1309921
• Correction: Cisplatinresistance can be curtailed by blunting Bnip3-mediated mitochondrialautophagy.Vianello C, Cocetta V, Catanzaro D, Dorn GW 2nd, De Milito A, Rizzolio F, Canzonieri V, Cecchin E, Roncato R, Toffoli G, Quagliariello V, Di Mauro A, Losito S, Maurea N, Scaffa C, Sales G, Scorrano L, Giacomello M, Montopoli M.Cell Death Dis. 2023 Aug 15;14(8):521. doi: 10.1038/s41419-023-05901-1.PMID: 37582906
• Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.Irma Bisceglia Maria Laura Canale Nicola Silvestris Giuseppina Gallucci Andrea CameriniAlessandro InnoMassimiliano CamilliFabio Maria Turazza Giulia RussoAndrea PacconeRaffaella Mistrulli Leonardo De LucaStefania Angela Di FuscoLuigi TarantiniFabiana LucàStefano OlivaAntonella Moreo MaureaNVincenzo QuagliarielloGiuseppina Rosaria RicciardiChiara LestuzziDamiana FiscellaIris ParriniVito RacanelliAntonio RussoLorena IncorvaiaFabio CalabròGiuseppe CuriglianoSaverio CinieriMichele Massimo GuliziaDomenico Gabrielli Fabrizio Oliva Furio Colivicch. Front. Cardiovasc. Med., 15 September 2023 Sec. Cardio-Oncology Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1223660
• Fastingmimickingdiet in mice delayscancergrowth and reducesimmunotherapy-associatedcardiovascular and systemic side effects. S. Cortellino, V. Quagliariello, G. Delfanti, O. Blaževitš, C. Chiodoni, Maurea N., A. Di Mauro, F. Tatangelo, F. Pisati , A. Shmahala , S. Lazzeri , V. Spagnolo , E. Visco , C. Tripodo , G. Casorati , P. Dellabona, V. D. Longo. doi.org/10.1038/s41467-023-41066-3
• Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy.Caterina Vianello , Veronica Cocetta , Daniela Catanzaro, Gerald W Dorn II, Angelo De Milito, Flavio Rizzolio, Vincenzo Canzonieri, Erika Cecchin , Rossana Roncato, Giuseppe Toffoli, Vincenzo Quagliariello, Annabella Di Mauro, Simona Losito, Maurea N., Cono Scaffa, Gabriele Sales, Luca Scorrano, Marta Giacomello and Monica Montopoli. Cell Death and Disease (2023) 14:521 ; https://doi.org/10.1038/s41419-023-05901-1
• CirculatingVitamin D Level and Its Impact on Mortality and Recurrence in Stage III ColorectalCancerPatients: A SystematicReview and Meta-Analysis.
• Ottaiano A, Facchini S, Santorsola M, Nasti G, Facchini G, Montella L, Maurea N, Cascella M, Iervolino D, Facchini BA, Montopoli M, Consolo P, Quagliariello V, Rinaldi L, Berretta M.Cancers (Basel). 2023 May 31;15(11):3012. doi: 10.3390/cancers15113012.PMID: 37296974
• COMBINATION OF SPIRULINA, GANODERMA LUCIDUM AND MORINGA OLEIFERA IMPROVES CARDIAC FUNCTIONS AND REDUCES PRO –INFLAMMATORY BIOMARKERS IN PRECLINICAL MODELS OF SHORT –TERM DOXORUBICIN – MEDIATED CARDIOTOXICITY V. Quagliariello, C. Ostacolo, R. De Anseris, A. Di Mauro, G. Scognamiglio, G. Palma, M. Iovine, A. Luciano, M. Barbieri, F. Bruzzese, F. Maurea, A. Paccone, M. Berretta, and Maurea N.European Heart Journal Supplements, Volume 25, IssueSupplement_D, May 2023, Page D3, https://doi.org/10.1093/eurheartjsupp/suad111.007
• Maintenance of intestinalepithelial barrier integrity by a combination of probiotics, herbalextract, and vitamins.Cocetta V, Giacomini I, Tinazzi M, Berretta M, Quagliariello V, Maurea N, Ragazzi E, Carnevali I, Montopoli M.MinervaPediatr (Torino). 2023 May 11. doi: 10.23736/S2724-5276.23.07128-8. Online ahead of print.PMID: 37166776
• CardiovascularEffects of Immune Checkpoint Inhibitors: More Than Just Myocarditis.Inno A, Tarantini L, Parrini I, Spallarossa P, Maurea N, Bisceglia I, Silvestris N, Russo A, Gori S.CurrOncol Rep. 2023 Jul;25(7):743-751. doi: 10.1007/s11912-023-01411-7. Epub 2023 Apr5.PMID: 37017825 Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story.
• Bisceglia I, Canale ML, Gallucci G, Turazza FM, Lestuzzi C, Parrini I, Russo G, Maurea N, Quagliariello V, Oliva S, Angela Di Fusco S, Lucà F, Tarantini L, Trambaiolo P, Moreo A, Geraci G, Gabrielli D, Gulizia MM, Oliva F, ColivicchiF.FrontCardiovascMed. 2023 Mar 9;10:1169176. doi: 10.3389/fcvm.2023.1169176. eCollection 2023.PMID: 36970365.
• PCSK9 Inhibitors in CancerPatientsTreated with Immune-Checkpoint Inhibitors to Reduce CardiovascularEvents: New Frontiers in Cardioncology.Quagliariello V, Bisceglia I, Berretta M, Iovine M, Canale ML, Maurea C, Giordano V, Paccone A, Inno A, MaureaN.Cancers (Basel). 2023 Feb 22;15(5):1397. doi: 10.3390/cancers15051397.PMID: 36900189
• Corrigendum: Immune checkpoint inhibitortherapyincreasessystemic SDF-1, cardiacDAMPsFibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.Quagliariello V, Passariello M, Di Mauro A, Cipullo C, Paccone A, Barbieri A, Palma G, Luciano A, Buccolo S, Bisceglia I, Canale ML, Gallucci G, Inno A, De Lorenzo C, MaureaN. FrontCardiovascMed. 2023 Jan 19;10:1129873. doi: 10.3389/fcvm.2023.1129873. eCollection 2023.PMID: 36742077
• SPIRULINA, GANODERMA LUCIDUM AND MORINGA IMPROVES CARDIAC FUNCTION AND REDUCES CARDIOTOXIC BIOMARKERS IN PRECLINICAL MODELS OF SHORT-TERM DOXORUBICIN MEDIATED CARDIOTOXICITY Vincenzo Quagliariello , Carmine Ostacolo , Raffaele De Anseris , Annabella Di Mauro , Giosuè Scognamiglio , Giuseppe Palma , Simona Buccolo , Antonio Luciano , Massimiliano Barbieri , Francesca Bruzzese , Fabrizio Maurea , Massimiliano Berretta , Claudia Saviano , and Maurea N. European Heart Journal Supplements, Volume 24, IssueSupplement_K, December 2022, suac121.134, https://doi.org/10.1093/eurheartjsupp/suac121.134
• SGLT-2 INHIBITOR DAPAGLIFLOZIN REDUCES ANTHRACYCLINE-MEDIATED CARDIOMYOPATHY IN PRECLINICAL MODELS THROUGH REDUCTION OF MYOCARDIAL NF-KB, MYD-88 AND NLRP3 EXPRESSION: A BIOCHEMICAL AND HISTOLOGICAL STUDY. Vincenzo Quagliariello, Simona Buccolo, Antonietta Caronna, Carlo Maurea , Andrea Paccone , Claudia Saviano, Annamaria Bonelli, Gabriele Conforti , and Maurea N.December 2022. European Heart Journal Supplements 24(Supplement_K)DOI: 10.1093/eurheartjsupp/suac121.135.
• Womenatheart: Introducing gender cardio-oncology.Canale ML, Bisceglia I, Gallucci G, Russo G, Camerini A, Di Fusco SA, Paccone A, Camilli M, Fiscella D, Lestuzzi C, Turazza FM, Gulizia MM, Pavan D, Maurea N, Gabrielli D, Oliva F, Colivicchi F. Womenatheart: Introducing gender cardio-oncology. Front CardiovascMed. 2022 Nov23;9:974123. doi: 10.3389/fcvm.2022.974123. PMID: 36505385; PMCID: PMC9726754.
• Immune checkpoint inhibitortherapyincreasessystemic SDF-1, cardiacDAMPsFibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.Quagliariello V, Passariello M, Di Mauro A, Cipullo C, Paccone A, Barbieri A, Palma G, Luciano A, Buccolo S, Bisceglia I, Canale ML, Gallucci G, Inno A, De Lorenzo C, Maurea N. Front CardiovascMed. 2022 Sep8;9:930797. doi: 10.3389/fcvm.2022.930797. eCollection 2022. PMID: 36158826.
• Dapagliflozinassociated to sacubitril/valsartan and relationship with cardioprotection in human cardiaccellsexposed to doxorubicin and HER2-blocking agents through MyD88, NLRP3 mediatedpathways. Maurea N. , Vincenzo Quagliariello, Martina Iovine, Simona Buccolo, Andrea Paccone, Irma Bisceglia, and Michelino De LaurentiisAUTHORS INFO & AFFILIATIONS Publication: Journal of ClinicalOncology Volume 40, Number 16_suppl https://doi.org/10.1200/JCO.2022.40.16_suppl.587
• Bisceglia I, Canale ML, Gallucci G, Turazza FM, Lestuzzi C, Parrini I, Russo G, Maurea N, Quagliariello V, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Moreo A, Geraci G, Gabrielli D, Gulizia MM, Oliva F, Colivicchi F.Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story- Front Cardiovasc Med. 2022 Jan 28;9:821193. doi: 10.3389/fcvm.2022.821193. eCollection 2022.Maurea N, Vincenzo Quagliariello, Andrea Paccone, Michelino De Laurentiis, Simona Buccolo, Martina Iovine, and Gerardo Botti ;Cytoprotective effects of spirulina extract against doxorubicin‐induced cardiotoxicity: Biochemical evidences and translational perspectives in cardio-oncology. Journal of Clinical Oncology 2021 39:15_suppl, e15042-e15042
• Quagliariello V, Paccone A, Iovine M, Cavalcanti E, Berretta M, Maurea C, Canale ML, Maurea N., Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19 , Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6797-6812. doi: 10.26355/eurrev_202111_27124.
• Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F.,ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)G Ital Cardiol (Rome). 2021 Oct;22(10):800-825. doi: 10.1714/3666.36511.
• V Quagliariello, A Bonelli, A Paccone, S Buccolo, M Iovine, G Conforti, G Botti, Maurea N, Evolocumab, a PCSK9 inhibitor, co-incubated with doxorubicin and trastuzumab reduces death of cardiomyocytes through reduction of MyD88-NLRP3-NF-kB-mTORC1;
• European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.2839, https://doi.org/10.1093/eurheartj/ehab724.2839 Published: 14 October 2021
• V Quagliariello, A Bonelli, A Paccone, S Buccolo, M Iovine, G Botti, Maurea N; Oxidized Low-Density Lipoproteins increases nivolumab-induced cardiotoxicity through TLR4/NF-KB and NLRP3 pathways. European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.2837, https://doi.org/10.1093/eurheartj/ehab724.2837 Published: 14 October 2021
• Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi FANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO) - Eur Heart J Suppl. 2021 Aug 26;23(Suppl C):C128-C153. doi: 10.1093/eurheartj/suab067
• Ronchi A, Grauso F, Zito Marino F, Quagliariello V, Maurea N, Facchini G, Montopoli M, Franco R, Berretta M, Messalli EM.Endocannabinoid system expression in ovarian epithelial tumors according to the dualistic model of ovarian carcinogenesis, Eur Rev Med Pharmacol Sci. 2021 Jul;25(14):4678-4686. doi: 10.26355/eurrev_202107_26378.
• Quagliariello V, De Laurentiis M, Rea D, Barbieri A, Monti MG, Carbone A, Paccone A, Altucci L, Conte M, Canale ML, Botti G, Maurea N. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin , Cardiovasc Diabetol. 2021 Jul 23;20(1):150. doi: 10.1186/s12933-021-01346-y
• Canale ML, Turazza F, Lestuzzi C, Parrini I, Camerini A, Russo G, Colivicchi F, Gabrielli D, Gulizia MM, Oliva S, Tarantini L, Maurea N, Rigacci L, Petrolati S, Casolo G, Bisceglia I. Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey Front Cardiovasc Med. 2021 Jun 16;8:677544. doi: 10.3389/fcvm.2021.677544. eCollection 2021.
• Quagliariello V, Berretta M, Buccolo S, Iovine M, Paccone A, Cavalcanti E, Taibi R, Montopoli M, Botti G, Maurea N. Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression Front Oncol. 2021 Jun 11;11:680758. doi: 10.3389/fonc.2021.680758. eCollection 2021
• Quagliariello V, D'Aiuto G, Iaffaioli RV, Berretta M, Buccolo S, Iovine M, Paccone A, Cerrone F, Bonanno S, Nunnari G, Laganà N, Botti G, Maurea N.Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctions Eur Rev Med Pharmacol Sci. 2021 May;25(10):3898-3907. doi: 10.26355/eurrev_202105_25957
• Carbone A, Bottino R, Russo V, D'Andrea A, Liccardo B, Maurea N, Quagliariello V, Cimmino G, Golino P - Takotsubo Cardiomyopathy as Epiphenomenon of Cardiotoxicity in Patients With Cancer: A Meta-summary of Case Reports - J Cardiovasc Pharmacol 2021 Jul 1;78(1):e20-e29. doi: 10.1097/FJC.0000000000001026
• Nicola Maurea, Vincenzo Quagliariello, Andrea Paccone, Michelino De Laurentiis, Simona Buccolo, Martina Iovine, Gerardo Botti, Cytoprotective effects of spirulina extract against doxorubicin‐induced cardiotoxicity: Biochemical evidences and translational perspectives in cardio-oncology. DOI: 10.1200/JCO.2021.39.15_suppl.e15042 Journal of Clinical Oncology 39, no. 15_suppl
• Inno A, Maurea N, Metro G, Carbone A, Russo A, Gori S- Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports- Cancer Immunol Immunother. 2021 Apr 20.
• Berretta M, Quagliariello V, Maurea N, Di Francia R, Sharifi S, Facchini G, Rinaldi L, Piezzo M, Manuela C, Nunnari G, Montopoli M -Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies- Antioxidants (Basel). 2020 Nov 26;9(12):1182
• Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A, Berretta M, Botti G, Maurea N. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer PatientsCancers (Basel). 2020 Nov 10;12(11):3316
• Barbieri A, Robinson N, Palma G, Maurea N, Desiderio V, Botti G Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer Front Immunol. 2020 Sep 30;11:588724.
• Quagliariello V, De Laurentiis M, Cocco S, Rea G, Bonelli A, Caronna A, Lombari MC, Conforti G, Berretta M, Botti G, Maurea N NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells - Int J Mol Sci. 2020 Oct 21;21(20):7802.
• Gulizia Chairperson MM, Parrini Co-Chairperson I, Colivicchi Co-Chairperson F, Bisceglia I, Caiazza F, Gensini GF, Mureddu GF, Santomauro M, Ageno W, Ambrosetti M, Aspromonte N, Barni S, Bellocci F, Caldarola P, Carletti M, De Luca L, Di Fusco SA, Di Lenarda A, Di Nisio M, Domenicucci S, Enea I, Francese GM, Lestuzzi C, Lucà F, Maurea N, Nassiacos D, Pedretti RFE, Pusineri E, Roscio G, Rossini R, Russo A, Volterrani M, Gabrielli Co-Chairperson D. - [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence] - G Ital Cardiol (Rome). 2020 Sep;21(9):687-738
• Vincenzo Quagliariello , Margherita Passariello , Domenica Rea , Antonio Barbieri , Martina Iovine , Annamaria Bonelli , Antonietta Caronna , Gerardo Botti , Claudia De Lorenzo, Nicola Maurea Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models- J Pers Med 2020 Oct 19;10(4):E179.
• Avallone, A., Piccirillo, M.C., Di Gennaro, E., Romano, C, Calabrese, F., Roca, M.S., Tatangelo, F., Granata, V, Cassata, A., Cavalcanti, E., Maurea, N., Maiolino, P., Silvestro, L., De Stefano, A., Giuliani, F., Rosati, G, Tamburini, E., Aprea, P, Vicario, V Nappi, A., Vitagliano, C., Casaretti, R, Leone, A., Petrillo, A., Botti, G., Delrio, P., Izzo, F, Perrone, F, Budillon, A.- Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol - Therapeutic Advances in Medical Oncology. Volume 12, 2020
• Quagliariello, V. Bonelli, A. Caronna, A. Lombari, M.C. Conforti, G. Libutti, M. Iaffaioli, R.V. Berretta, M.Botti, G. Maurea, N. - SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications? - European Review for Medical and Pharmacological Sciences Volume 24, Issue 17, 2020, Pages 9169-9171
• Quagliariello, V.Vecchione, R. De Capua, A.Lagreca, E.Iaffaioli, R.V.Botti, G. Netti, P.A.Maurea, N- Nano-encapsulation of coenzyme q10 in secondary and tertiary nano-emulsions for enhanced cardioprotection and hepatoprotection in human cardiomyocytes and hepatocytes during exposure to anthracyclines and trastuzumab - International Journal of Nanomedicine - Volume 15, 2020, Pages 4859-4876
• Barbieri, A., Robinson, N.,Palma, G. Maurea, N. Desiderio, V., Botti, G. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?—Lessons Learned From Cancer - Frontiers in Immunology Volume 11, 30 September 2020, Article number 588724
• Canale, M.L.Camerini, A.Casolo, G.Lilli, A.Bisceglia, I.Lestuzzi, C.Del Meglio, J.Puccetti, C.Camerini, L.Amoroso, D.,Maurea, N. Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy- Advances in Therapy 37(7), pp. 3178-3184 2020
• Berretta, M Bignucolo A. Di Francia R. Comello F Facchini, G, Ceccarelli, M, Iaffaioli, R.V. Quagliariello, V.Maurea, N- Resveratrol in cancer patients: From bench to bedside - International Journal of Molecular Sciences 2020 Volume 21, Issue 8, 2 April 2020, Article number 2945
• Calcagno V, Vecchione R, Quagliariello V, Marzola P, Busato A, Giustetto P, Profeta M, Gargiulo S, Cicco CD, Yu H, Cassani M, Maurea N, Mancini M, Pellegrino T, Netti PA. Oil Core-PEG Shell Nanocarriers for In Vivo MRI Imaging. Adv Healthc Mater. 2019 Feb;8(3):e1801313. doi: 10.1002/adhm.201801313. Epub 2019 Jan 7.
• Pascarella G, Capasso A, Nardone A, Triassi M, Pignata S, Arenare L, Ascierto P, Curvietto M, Maiolino P, D'Aniello R, Montanino A, Laudato F, De Feo G, Botti G, Perrone F, Petrillo A, Cavalcanti E, Lastoria S, Maurea N, Morabito A. Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology. PLoS One. 2019 Jan 8;14(1):e0210330. doi: 10.1371/journal.pone.0210330. eCollection 2019.
• Quagliariello V, Coppola C, Mita DG, Piscopo G, Iaffaioli RV, Botti G, Maurea N. Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts. Environ Toxicol Pharmacol. 2019 Jul;69:1-8. doi: 10.1016/j.etap.2019.03.006. Epub 2019 Mar 7.
• Barbarisi M, Barbarisi A, De Sena G, Armenia E, Aurilio C, Libutti M, Iaffaioli RV, Botti G, Maurea N, Quagliariello V. Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells. Phytother Res. 2019 Jun;33(6):1670-1682. doi: 10.1002/ptr.6354. Epub 2019 Mar 28.
• Quagliariello V, Passariello M, Coppola C, Rea D, Barbieri A, Scherillo M, Monti MG, Iaffaioli RV, De Laurentiis M, Ascierto PA, Botti G, De Lorenzo C, Maurea N.Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab.Int J Cardiol. 2019 Oct 1;292:171-179. doi: 10.1016/j.ijcard.2019.05.028. Epub 2019 May 17.
• Quagliariello V, Vecchione R, Coppola C, Di Cicco C, De Capua A, Piscopo G, Paciello R, Narciso V, Formisano C, Taglialatela-Scafati O, Iaffaioli RV, Botti G, Netti PA, Maurea N. Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity. Nutrients. 2018 Sep 14;10(9)
• Riccio G, Antonucci S, Coppola C, D’Avino C, Piscopo G, Fiore D, Maurea C, Russo M, Rea D, Arra C, Condorelli G, Di Lisa F, Tocchetti CG, De Lorenzo C, Maurea N. Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production. Front. Physiol. 2018 Feb 6; 9:38
• De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N. Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of Ranolazine. OncoTargets and therapy, 2018 Apr 19; 11:2241-2250
• Calabrese V, Menna P, Annibali O, Armento G, Carpino A, Cerchiara E, Greco C, Marchesi F, Spallarossa P, Toglia G, Reggiardo G, Minotti G; Collaborators. Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study. Chemotherapy. 2018;63(2):55-63.
• Coppola C, Rienzo A, Piscopo G, Barbieri A, Arra C, Maurea N. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs. Cancer Treat Rev. 2017 Dec 6;63:135-143.
• Fotticchia T, Vecchione R, Scognamiglio PL, Guarnieri D, Calcagno V, Di Natale C, Attanasio C, De Gregorio M, Di Cicco C, Quagliariello V, Maurea N, Barbieri A, Arra C, Raiola L, Iaffaioli RV, Netti PA. Enhanced Drug Delivery into Cell Cytosol via Glycoprotein H-Derived Peptide Conjugated Nanoemulsions. ACS Nano. 2017 Oct 24;11(10):9802-9813
• Luigi Tarantini (Coordinator), Michele Massimo Gulizia, FACC, FESC (Coordinator), Andrea Di Lenarda, FACC, FESC (Coordinator), Nicola Maurea, FACC, FESC (Coordinator), Maurizio Giuseppe Abrignani, Irma Bisceglia, Daniella Bovelli, Luisa De Gennaro, Donatella Del Sindaco, Francesca Macera, Iris Parrini, Donatella Radini, Giulia Russo, Angela Beatrice Scardovi, and Alessandro Inno. [ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary]. European Heart Journal Supplements (2017) 19 (Supplement D), D370–D379.
• Maurea N, Ragone G, Coppola C, Caronna A, Tocchetti CG, Agozzino L, Apice G, Iaffaioli RV. Intracardiac metastasis originated from chondrosarcoma. J Cardiovasc Med (Hagerstown). 2017 May;18(5):385-388Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N. Antineoplastic related cardiotoxicity, morphofunctional aspects in murine model: contribution of the new tool 2D-speckle tracking. Oncotarget and therapy 2016 Nov 2;9:6785-6794.Rea D, Coppola C, Barbieri A, Monti MG, Misso G, Palma G, Bimonte S, Zarone MR, Luciano A, Liccardo D, Maiolino P, Cittadini A, Ciliberto G, Arra C, Maurea N. Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research. In Vivo. 2016 May-Jun;30(3):279-90.
• Maurea N, Spallarossa P, Cadeddu C, Madonna R, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Tocchetti CG, Zito C, Mercuro G. A reccommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S93-S104.
• Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, Esposito E, De Lorenzo C, De Laurentiis M, Spallarossa P, Mercuro G. Pathophysiology of Cardiotoxicity from Target Therapy and Angiogenesis Inhibitors. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S19-26
• Spallarossa P, Maurea N, Cadeddu C, Mele D, Tocchetti CG, Pagliaro P, Madonna R, Monte I, Novo G, Pepe A, Zito C, Mercuro G. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S84-92
• Mele D, Tocchetti CG, Pagliaro P, Madonna R, Novo G, Pepe A, Zito C, Maurea N, Spallarossa P. Pathophysiology of anthracycline cardiotoxicity. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S3-S11
• Riccio G, Coppola C, Piscopo G, Capasso I, Maurea C, Esposito E, De Lorenzo C, Maurea N.Trastuzumab and target-therapy side effects: is still valid to differentiate anthracycline Type I from Type II. Cosmi F, Di Giulio P, Masson S, Finzi A, Marfisi RM, Cosmi D, Scarano M, Tognoni G, Maggioni AP, Porcu M, Boni S, Cutrupi G, Tavazzi L, Latini R; GISSI-HF Investigators. Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers. Circ Heart Fail. 2015 May;8(3):428-37
• Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D Angelo V, Granata C, Cavalcanti E, Maurea N, Maiolino P, Bianco F, Montano M, Silvestro L, Barberio MT, Roca MS, Di Maio M, Marone P, Botti G, Petrillo A, Daniele G, Lastoria S, Iaffaioli VR, Romano G, Caracò C, Muto P, Gallo C, Perrone F, Budillon A. Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial). BMC Cancer. 2014 Nov 24;14(1):875
• Capasso I, Esposito E, de Laurentiis M, Maurea N, Cavalcanti E, Botti G, Petrillo A, Montella M, D'Aiuto M, Coppola C, Crispo A, Grimaldi M, Frasci G, Fucito A, Ciliberto G, D'Aiuto G. Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype. Diabetol Metab Syndr. 2014 Sep 26;6(1):105
• Russo G, Cioffi G, Gori S, Tuccia F, Boccardi L, Khoury G, Lestuzzi C, Maurea N, Oliva S, Faggiano P, Tarantini L; ICARO (Italian CARdio-Oncological) Network. Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer. J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):141-6
• Tocchetti CG, Carpi A, Coppola C, Quintavalle C, Rea D, Campesan M, Arcari A, Piscopo G, Cipresso C, Monti MG, De Lorenzo C, Arra C, Condorelli G, Di Lisa F, Maurea N. Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction. Eur J Heart Fail. 2014 Apr;16(4):358-66
• D'Avino C, Paciello R, Riccio G, Coppola M, Laccetti P, Maurea N, Raines RT, De Lorenzo C. Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells. Protein Eng Des Sel. 2014 Mar;27(3):83-8.
• Askevold ET, Aukrust P, Nymo SH, Lunde IG, Kaasbøll OJ, Aakhus S, Florholmen G, Ohm IK, Strand ME, Attramadal H, Fiane A, Dahl CP, Finsen AV, Vinge LE, Christensen G, Yndestad A, Gullestad L, Latini R, Masson S, Tavazzi L; GISSI-HF Investigators, Ueland T.The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure.J Intern Med. 2014 Jun;275(6):621-30
• Capasso I, Esposito E, Maurea N, Montella M, Crispo A, De Laurentiis M, D'Aiuto M, Frasci G, Botti G, Grimaldi M, Cavalcanti E, Esposito G, Fucito A, Brillante G, D'Aiuto G, Ciliberto G. Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial.Trials. 2013 Aug 28;14(1):273
• Capasso I, Esposito E, Pentimalli F, Montella M, Crispo A, Maurea N, D Aiuto M, Fucito A, Grimaldi M, Cavalcanti E, Esposito G, Brillante G, Lodato S, Pedicini T, D Aiuto G, Ciliberto G, Giordano A. Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: national cancer institute of Naples experience. J Exp Clin Cancer Res. 2013 Mar 14;32(1):14
• Tocchetti CG, Gallucci G, Coppola C, Piscopo G, Cipresso C, Maurea C, Giudice A, Iaffaioli RV, Arra C, Maurea N. The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors. Eur J Heart Fail. 2013 May; 15(5):482-9.
• Gallucci G, Tartarone A, Tocchetti CG, Bochicchio AM, Coccaro M, Capobianco A, Maurea N, Improta G, Zupa A, Aieta M. Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literature. Future Oncol. 2013 Jan;9(1):127-33
• Tarantini L, Gori S, Faggiano P, Pulignano G, Simoncini E, Tuccia F, Ceccherini R, Bovelli D, Lestuzzi C, Cioffi G, Lestuzzi C, Fioretti SO, Giotta F, Latorre A, Tarantini L, Russo P, Sardina G, Catania G, Tuccia F, Laveder F, Faggiano P, Triggiani M, Simoncini E, Severini D, Di Tano G, Generali D, Gabrielli D, Pennacchietti L, Cardinali L, Maurea N, Lombari MC, De Laurentis M, Pacilio C, Gori S, Alunni G, Carluccio E, Boccardi L, Fini F, Pulignano G, Bovelli D, De Bonis P, Nunzi M, Sabatini S, Russo G, Di Lenarda A, Ceccherini R; ICARO (Italian CARdio-Oncologic) Network. Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis. Ann Oncol. 2012 Dec;23(12):3058-63
• Oliva S, Cioffi G, Frattini S, Simoncini EL, Faggiano P, Boccardi L, Pulignano G, Fioretti AM, Giotta F, Lestuzzi C, Maurea N, Sabatini S, Tarantini L; Italian Cardio-Oncological Network. Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world? Oncologist. 2012;17(7):917-24
• Tarantini L, Cioffi G, Gori S, Tuccia F, Boccardi L, Bovelli D, Lestuzzi C, Maurea N, Oliva S, Russo G, Faggiano P; Italian Cardio-Oncologic Network. Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer. J Card Fail. 2012 Feb;18(2):113-9
• Tocchetti CG, Ragone G, Coppola C, Rea D, Piscopo G, Scala S, De Lorenzo C, Iaffaioli RV,Arra C, Maurea N. Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge. Eur J Heart Fail. 2012 Feb;14(2):130-7
• Tocchetti CG, Coppola C, Arra C, Maurea N. Early identification of left ventricular dysfunction induced by trastuzumab. J Am Coll Cardiol. 2011 Dec 13;58(25): 2698-9
• Fedele C, Riccio G, Coppola C, Barbieri A, Monti MG, Arra C, Tocchetti CG, D'Alessio G, Maurea N, De Lorenzo C. Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors. Breast Cancer Res Treat. 2012 Jun;133(2):511-21
• Tocchetti CG, Lombari MC, Librera M, Ascierto PA, Maurea N. Complete atrioventricular block in a patient with intracardiac metastases from malignant melanoma. Eur J Echocardiogr. 2011 Aug;12(8):636
• Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, De Marco M, Cavalcanti E, D'Aiuto M, Fucito A, Frasci G, Maurea N, Esposito G, Pedicini T, Vecchione A, D'Aiuto G, Giordano A. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.Cancer Biol Ther. 2010 Dec 15;10(12):1240-3. Epub 2010 Dec 15.
• Giudice A, Caraglia M, Marra M, Montella M, Maurea N, Abbruzzese A, Arra C. Circadian rhythms, adrenergic hormones and trafficking of hematopoietic stem cells. Expert Opin Ther Targets. 2010 May;14(5):567-75. doi: 10.1517/14728221003769887.
• Maurea N, Coppola C, Ragone G, Frasci G, Bonelli A, Romano C, Iaffaioli RV. Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med (Hagerstown). 2010 Dec;11(12):861-8. doi: 10.2459/JCM.0b013e328336b4c1.
• Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4;372(9645):1223-30. doi: 10.1016/S0140-6736(08)61239-8. Epub 2008 Aug 29.
• Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4;372(9645):1231-9. doi: 10.1016/S0140-6736(08)61240-4. Epub 2008 Aug 29.
• De Maio E, Pacilio C, Gravina A, Morabito A, Di Rella F, Labonia V, Landi G, Nuzzo F, Rossi E, Silvestro P, Botti G, Di Bonito M, Curcio MP, Formichelli F, La Vecchia F, Staiano M, Maurea N, D'Aiuto G, D'Aiuto M, Thomas R, Signoriello G, Perrone F, de Matteis A. Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.BMC Cancer. 2007 Mar 20;7:50.
• Maurea N, Mollo A, Boccalatte M, Esposito S, Agozzino L, Bellitti R. Lipoma of the heart: a case report. Ital Heart J. 2001 Aug;2(8):621-3.
• Vigorito C, Giordano A, Maurea N, Casaburi E, Maurelli B, Farese N, Longobardi G, Abete P, Rumolo S, Rengo F.Cardiologia.Effects of histamine on coronary circulation in man. 1988 Feb;33(2):195-200
• Vigorito C, Giordano A, De Caprio L, Vitale DF, Maurea N, Silvestri P, Tuccillo B, Ferrara N, Marone G, Rengo F. Effects of histamine on coronary hemodynamics in humans: role of H1 and H2 receptors. J Am Coll Cardiol. 1987 Dec;10(6):1207-13.
• Vigorito C, Giordano A, Maurea N, Tuccillo B, Rengo F. Rapid relief of spontaneous angina by intraventricular diltiazem: systemic and regional coronary haemodynamic determinants. Eur Heart J. 1987 Aug;8(8):910-1.
• Vigorito C, Giordano A, De Caprio L, Vitale D, Ferrara N, Tuccillo B, Maurea N, Rispoli M, Rengo F. Direct coronary vasodilator effects of intracoronary histamine administration in humans. J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):933-9.
• Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI‐HF Investigators. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005156. doi: 10.1161/JAHA.116.005156.
• Cosmi F, Di Giulio P, Masson S, Finzi A, Marfisi RM, Cosmi D, Scarano M, Tognoni G, Maggioni AP, Porcu M, Boni S, Cutrupi G, Tavazzi L, Latini R; GISSI-HF Investigators. Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers. Circ Heart Fail. 2015 May;8(3):428-37. doi: 10.1161/Circ Heart Failure.114.002091. Epub 2015 Apr 29.

No content available to display!!!

No content available to display!!!